Correlation Between NRX Pharmaceuticals and NISOURCE

Can any of the company-specific risk be diversified away by investing in both NRX Pharmaceuticals and NISOURCE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NRX Pharmaceuticals and NISOURCE into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NRX Pharmaceuticals and NISOURCE FIN P, you can compare the effects of market volatilities on NRX Pharmaceuticals and NISOURCE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NRX Pharmaceuticals with a short position of NISOURCE. Check out your portfolio center. Please also check ongoing floating volatility patterns of NRX Pharmaceuticals and NISOURCE.

Diversification Opportunities for NRX Pharmaceuticals and NISOURCE

0.11

Correlation Coefficient

NRX Pharmaceuticals  NISOURCE

Average diversification

The 3 months correlation between NRX and NISOURCE is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding NRX Pharmaceuticals and NISOURCE FIN P in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NISOURCE FIN P and NRX Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NRX Pharmaceuticals are associated (or correlated) with NISOURCE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NISOURCE FIN P has no effect on the direction of NRX Pharmaceuticals i.e., NRX Pharmaceuticals and NISOURCE go up and down completely randomly.

Pair Corralation between NRX Pharmaceuticals and NISOURCE

Given the investment horizon of 90 days NRX Pharmaceuticals is expected to generate 45.02 times more return on investment than NISOURCE. However, NRX Pharmaceuticals is 45.02 times more volatile than NISOURCE FIN P. It trades about 0.11 of its potential returns per unit of risk. NISOURCE FIN P is currently generating about -0.06 per unit of risk. If you would invest  142.00  in NRX Pharmaceuticals on December 22, 2024 and sell it today you would earn a total of  66.00  from holding NRX Pharmaceuticals or generate 46.48% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	91.67%
Values	Daily Returns

NRX Pharmaceuticals  vs.  NISOURCE FIN P

NRX Pharmaceuticals

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in NRX Pharmaceuticals are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, NRX Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

NISOURCE FIN P

Risk-Adjusted Performance

Very Weak

Over the last 90 days NISOURCE FIN P has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, NISOURCE is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with NRX Pharmaceuticals and NISOURCE

The main advantage of trading using opposite NRX Pharmaceuticals and NISOURCE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NRX Pharmaceuticals position performs unexpectedly, NISOURCE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NISOURCE will offset losses from the drop in NISOURCE's long position.

The idea behind NRX Pharmaceuticals and NISOURCE FIN P pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.